Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Presage |
Description | Pioneering the Future of Translational Oncology About Us About Presage Team and Board Publications News Clinical Collaboration CIVO Platform Contact Us Re |
Keywords | N/A |
WebSite | presagebio.com |
Host IP | 52.24.10.57 |
Location | United States |
Site | Rank |
US$3,321,655
Last updated: 2022-07-12 12:41:02
presagebio.com has Semrush global rank of 3,186,455. presagebio.com has an estimated worth of US$ 3,321,655, based on its estimated Ads revenue. presagebio.com receives approximately 383,268 unique visitors each day. Its web server is located in United States, with IP address 52.24.10.57. According to SiteAdvisor, presagebio.com is safe to visit. |
Purchase/Sale Value | US$3,321,655 |
Daily Ads Revenue | US$3,067 |
Monthly Ads Revenue | US$91,985 |
Yearly Ads Revenue | US$1,103,812 |
Daily Unique Visitors | 25,552 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
presagebio.com. | A | 599 | IP: 52.24.10.57 |
presagebio.com. | NS | 3600 | NS Record: ns46.domaincontrol.com. |
presagebio.com. | NS | 3600 | NS Record: ns45.domaincontrol.com. |
presagebio.com. | MX | 1800 | MX Record: 10 presagebio-com.mail.protection.outlook.com. |
presagebio.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
presagebio.com. | TXT | 1800 | TXT Record: WsDs3/LxR065zvonof2qRxGd9UbDM6DbcV7JeYyJrEp2jwvurvZ2i/U3yd3vmO9bnpP4O34CZwx6nT6uD9rHtA== |
Pioneering the Future of Translational Oncology About Us About Presage Team and Board Publications News Clinical Collaboration CIVO Platform Contact Us Revolutionizing oncology drug development Presage is at the forefront of changing how novel cancer therapies are developed and promising drug combinations are identified. With Phase 0 microdose trials, evaluation of tumor-based drug activity is now possible earlier than ever before. Discover the benefit of phase 0 microdosing A bridge between early preclinical experimentation and clinical investigation Using Presage’s patented CIVO ® ( C omparative I n V ivo O ncology) platform, tumor microenvironment response to multiple investigational treatments, alone or in combination, can be observed where it matters most—in a patient’s tumor. See how CIVO works Presage Biosciences is an oncology company that is pioneering an entirely novel approach to evaluating drug responses in clinical trials. About Presage Presage’s patented CIVO ® ( C |
HTTP/1.1 302 Found Date: Sun, 31 Oct 2021 19:24:10 GMT Server: Apache/2.4.29 (Ubuntu) Location: https://presagebio.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sun, 31 Oct 2021 19:24:10 GMT Server: Apache/2.4.29 (Ubuntu) Last-Modified: Fri, 19 Mar 2021 21:56:27 GMT ETag: "2288-5bdeac9ab58c0" Accept-Ranges: bytes Content-Length: 8840 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: PRESAGEBIO.COM Registry Domain ID: 1526991153_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-11-05T12:17:29Z Creation Date: 2008-11-04T13:08:14Z Registry Expiry Date: 2022-11-04T13:08:14Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS45.DOMAINCONTROL.COM Name Server: NS46.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T05:11:55Z <<< |